1 Min Read
Dec 5 (Reuters) - Inspiremd Inc:
* INSPIREMD ANNOUNCES PRELIMINARY 2 YEAR FOLLOW-UP RESULTS FROM THE PARADIGM CLINICAL STUDY USING CGUARD™ EPS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.